EFSA reasoned opinion on the modification of the existing MRLs for cyflufenamid
Sign in to continue
Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access